National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 47595-47596 [2011-19881]
Download as PDF
Federal Register / Vol. 76, No. 151 / Friday, August 5, 2011 / Notices
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(2) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (3) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact: Dr.
Cathrine Sasek, Coordinator, Science
Education Program, Office of Science
Policy and Communications, National
Institute on Drug Abuse, 6001 Executive
Blvd, Room 5237, Bethesda, MD 20892,
or call non-toll-free number (301) 443–
6071; fax (301) 443–6277; or by e-mail
to csasek@nida.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
Dated: August 1, 2011.
Mary Affeldt,
Executive Officer, (OM Director, NIDA).
[FR Doc. 2011–19877 Filed 8–4–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
erowe on DSKG8SOYB1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Mar<15>2010
15:16 Aug 04, 2011
Jkt 223001
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Chronic Illness and Anxiety.
Date: August 23, 2011.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Monica Basco, PhD,
Scientific Review Officer, RPHB IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3220,
MSC 7808, Bethesda, MD 20892, 301–496–
7010, bascoma@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Biology and
Diseases of the Posterior Eye.
Date: September 13, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance, Washington, DC Hotel,
999 Ninth Street, NW., Washington, DC
20001–4427.
Contact Person: Noni Byrnes, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892, (301)-435–
1023, byrnesn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–09–
084: Developmental Biology Research.
Date: September 13–14, 2011.
Time: 1 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: John Burch, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 3213,
MSC 7808, Bethesda, MD 20892, 301–408–
9519, burchjb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; MIT Laser
Biomedical Research Center.
Date: September 14–16, 2011.
Time: 6 p.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Washington
DC Hotel, 2660 Woodley Road, NW.,
Washington, DC 20008.
Contact: Xiang-Ning Li, MD, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, 301–435–
1744, lixiang@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
47595
Group; Neural Basis of Psychopathology,
Addictions and Sleep Disorders Study
Section.
Date: September 15–16, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD 21202.
Contact: Boris P Sokolov, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5217A, MSC 7846, Bethesda,
MD 20892, 301–408–9115,
bsokolov@csr.nih.gov.
Name of Committee: Oncology 1–Basic
Translational Integrated Review Group;
Cancer Etiology Study Section.
Date: September 16, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: InterContinental Chicago Hotel, 505
North Michigan Avenue, Chicago, IL 60611.
Contact: Elaine Sierra-Rivera, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7804, Bethesda, MD 20892, 301–435–
1779, riverase@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 1, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–19878 Filed 8–4–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
E:\FR\FM\05AUN1.SGM
05AUN1
47596
Federal Register / Vol. 76, No. 151 / Friday, August 5, 2011 / Notices
Emphasis Panel; SUDEP Centers Without
Walls Planning Grants.
Date: August 25, 2011.
Time: 8:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Doubletree Hotel Chicago O’Hare
Airport-Rosemont, 5460 North River Road,
Rosemont, IL 60018.
Contact Person: William C. Benzing, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, 301–496–0660,
benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: July 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–19881 Filed 8–4–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Scientific Summit; The
Science of Compassion—Future
Directions in End-of-Life and Palliative
Care
Notice is hereby given that
the National Institute of Nursing
Research (NINR), National Institutes of
Health (NIH), Department of Health and
Human Services, will convene a
scientific summit titled ‘‘The Science of
Compassion—Future Directions in Endof-Life and Palliative Care.’’ The summit
is cosponsored by the NIH Office of Rare
Diseases Research, the NIH Office of
Research on Women’s Health, the
National Center for Complementary and
Alternative Medicine, the National
Institute on Aging, and the NIH Clinical
Center Department of Bioethics.
Portions of the event are supported by
the Foundation for the National
Institutes of Health and Pfizer.
DATES: The summit will begin
Wednesday evening, August 10, 2011,
7 p.m. to 9 p.m. and continue August
11–12.
ADDRESSES: The Summit will be held at
the Hyatt Regency in Bethesda,
Maryland, located at One Bethesda
Metro Center (7400 Wisconsin Avenue),
Bethesda, Maryland 20814.
FOR FURTHER INFORMATION CONTACT: To
register for the summit, please visit
https://www.ninr.nih.gov/
erowe on DSKG8SOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:16 Aug 04, 2011
Jkt 223001
ResearchAndFunding/
scienceofcompassion.htm. For
additional information, please contact
Ms. Crystal Esler, NINR, at
crystal.esler@nih.gov or 301–496–9629.
SUPPLEMENTARY INFORMATION: Increasing
numbers of Americans live for years
with serious, advanced illness and then
later die from the consequences of these
debilitating conditions. There is an
urgent need to improve the quality of
life for those with life-limiting
conditions through increased use of
evidence-based end-of-life and
palliative care (EOL PC) services. The
objectives of this summit are to examine
the current status of EOL PC research
and practice; propose strategies to
overcome barriers and ensure scientific
and methodologic rigor in EOL PC
research; delineate new action items
that galvanize progress in these vital
areas of science; and envision and map
pathways to ensure a future rich with
EOL PC scientific endeavor and
achievements. This summit, held in
conjunction with NINR’s
commemoration of its 25th Anniversary,
will bring together scientists, EOL PC
health professionals, educators,
members of professional organizations,
and individuals with life-limiting
illnesses, as well as their caregivers.
The summit will begin with a Town
Hall discussion on the evening of
August 10 on the ethics of science at the
end-of-life. On August 11–12, the
summit will feature keynote
presentations, three plenary
discussions, and break-out sessions.
Leading experts from interdisciplinary
fields of research will address a range of
EOL PC issues. A special lunch-hour
presentation on August 11 will feature
a dialogue on parents and clinicians as
partners in research. The summit will
conclude at 2 p.m. on August 12.
Dated: August 1, 2011.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2011–20004 Filed 8–4–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2011 Funding
Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award to the
National Council for Behavioral
Healthcare.
AGENCY:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award
approximately $3,800,000 (total costs)
for up to one year to the National
Council for Behavioral Healthcare. This
is not a formal request for applications.
Assistance will be provided only to the
National Council for Behavioral
Healthcare based on the receipt of a
satisfactory application that is approved
by an independent review group.
Funding Opportunity Title: SM–11–
013.
SUMMARY:
Catalog of Federal Domestic Assistance
(CFDA) Number: 93.243.
Authority: Section 520(A) of the Public
Health Service Act, as amended.
Justification: Eligibility for this
funding opportunity is limited to the
National Council for Community
Behavioral Healthcare (NCCBH) based
on the Council’s expertise and existing
relationship with the Primary and
Behavioral Health Care Initiative
(PBHCI) grantees.
The NCCBH, the current Training and
Technical Assistance Center for Primary
and Behavioral Health Care Initiative
(TTA–PBHCI) grantee, has an existing
relationship with the 56 PBHCI
grantees, for whom half of the technical
assistance will be developed. It already
has the infrastructure established to
provide day-to-day training and
technical assistance (both onsite and ebased). The NCCBH also has the
contacts and staff required to select and
manage selected state-designated
entities (SDEs) and provide the required
technical assistance to them.
Since supplemental funding is for
one-year, it is critical that the applicant
be able to quickly and effectively
initiate the activities required by the
cooperative agreement and the PBHCI
HIT grant. The NCCBH has the
foundation in place to make the best use
of the short period of time available.
There is no other organization with the
experience or background to ensure that
the objectives will be met and accurate
outcome measurements will be gathered
through performance data. The Council
has been involved in providing health
information technology information/
resources to its 1400+ members and has
existing affiliations with IT systems that
are acknowledged leaders in the field.
FOR FURTHER INFORMATION CONTACT:
Shelly Hara, Substance Abuse and
Mental Health Services Administration,
1 Choke Cherry Road, Room 8–1095,
Rockville, MD 20857; telephone: (240)
E:\FR\FM\05AUN1.SGM
05AUN1
Agencies
[Federal Register Volume 76, Number 151 (Friday, August 5, 2011)]
[Notices]
[Pages 47595-47596]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19881]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special
[[Page 47596]]
Emphasis Panel; SUDEP Centers Without Walls Planning Grants.
Date: August 25, 2011.
Time: 8:30 a.m. to 1:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: Doubletree Hotel Chicago O'Hare Airport-Rosemont, 5460
North River Road, Rosemont, IL 60018.
Contact Person: William C. Benzing, PhD, Scientific Review
Officer, Scientific Review Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Blvd., Suite
3208, MSC 9529, Bethesda, MD 20892, 301-496-0660,
benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: July 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-19881 Filed 8-4-11; 8:45 am]
BILLING CODE 4140-01-P